Similar drugsTo uncover
Dosage form: & nbspinjection
Composition:1 ml of the preparation contains: active substance - indigocarmine (in terms of dry matter) 4.0 mg; Excipients - sodium formaldehyde sulfoxylate dihydrate 0.5 mg, sodium hydro citrate sesquihydrate 1.0 mg, water for injection up to 1.0 ml.
Description:

A dark blue solution.

Pharmacotherapeutic group:Diagnostic tool
ATX: & nbsp
  • Tests for the determination of kidney function
  • Pharmacodynamics:

    Diagnostic tool from the group of dyes. The application is based on the ability of indigocarmine to be rapidly excreted unchanged in the urine without causing impaired renal function.

    Pharmacokinetics:Indigocarmine is excreted mainly by the kidneys, while retaining a blue color. Elimination begins within 10 minutes after administration. The half-life is about 4-5 minutes.
    Indications:

    Examination of excretory function of the kidneys, including renal pelvis and ureter, and dynamic activity of renal pelvis and ureter.

    For visual detection of violations of the integrity of the cavity organs and the extent of fistulous movements.

    Contraindications:Hypersensitivity to the components of the drug, side effects on the introduction of indigo carmine in history, pregnancy and lactation, children under 18 years.
    Carefully:Renal failure.
    Pregnancy and lactation:

    The use of the drug during pregnancy and during breast-feeding is contraindicated.

    Dosing and Administration:

    Intravenous, intracavitary, in fistulous courses.

    Before use, the preparation is heated to 37 ° C.

    Intravenously slowly - 5-20 ml of a solution of 4 mg / ml, if you can not enter the solution intravenously, enter intramuscularly in a volume of 20 ml (with the speed of the appearance of the drug in the urine decreases). Monitoring the excretion of indigo carmine with urine is carried out with the help of a cystoscope. With normal kidney function, the paint begins to secrete from the ureters after 2-3 minutes, the maximum elimination is observed after 6-8 minutes, ends after 1-1.5 hours. In patients with impaired renal function excretion is less intensive and more delayed.

    Intravenous or fistulous ducts, an undiluted solution of 4 mg / ml is administered or diluted immediately before use with 5 ml of a solution of 4 mg / ml (1 ampoule) in 400 ml of 0.9% sodium chloride solution.

    Side effects:

    Allergic reactions, idiosyncrasy, increased blood pressure.

    Overdose:

    Cases of overdose are not described. Treatment is symptomatic.

    Interaction:

    Pharmaceutically incompatible with other medicines, with the exception of 0.9% sodium chloride solution.

    Special instructions:

    Some patients may experience an increase in blood pressure.

    Effect on the ability to drive transp. cf. and fur:The drug is used only in a hospital.
    Form release / dosage:

    Solution for injection 4 mg / ml 5 ml in ampoules.

    Packaging:

    1, 2, 3, 4 or 5 ampoules into a contour mesh package made of a polyvinylchloride (PVC) film.

    1 or 2 contour mesh packages together with the instruction for use and the ampoule scarifier are placed in a cardboard box.

    10 ampoules together with the instruction for use and the ampoule scarifier are placed in a cardboard box with a corrugated liner.

    When using ampoules with a dot or a ring of fracture, the ampoule scaler is not they invest.

    Storage conditions:

    In the dark place at a temperature of 15 ° C to 25 ° C. Keep out of the reach of children.

    Shelf life:

    2 years. Do not use after the expiration date printed on the package.

    Terms of leave from pharmacies:On prescription
    Registration number:LP-001579
    Date of registration:11.03.2012
    The owner of the registration certificate:ELLARA, LTD. ELLARA, LTD. Russia
    Manufacturer: & nbsp
    Information update date: & nbsp11.09.2015
    Illustrated instructions
      Instructions
      Up